0.62 USD
▲+0.00+2.93%
盘后 0.60 -0.02%
2026-08-03
市值
$57.13M
市盈率
—
EPS
-0.42
股息率
—
52 周区间
0.55 – 3.62
成交量
945.36K
Beta
1.75
目标价
5.38
52W 低 0.5552W 高 3.62
价格走势
公司简介
Context Therapeutics Inc., a clinical-stage biopharmaceutical company, develops products for the treatment of solid tumors. The company’s product candidate includes CTIM-76, a Claudin 6 (CLDN6) x CD3 bispecific antibody that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6. It has a collaboration and licensing agreement with Integral Molecular, Inc. for the development of a CLDN6 bispecific monoclonal antibody for cancer therapy. The company was incorporated in 2015 and is headquartered in Philadelphia, Penn...